Overall rank by patents
#26,150
of 50,000 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).
The verdict
According to USPTO PatentsView, Dose ranks #26,150 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R26150 · US Corporation #26,150 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Dongguan Empress Technology Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Dose Health · this assignee
31 score
3D Lighting Innovati… · lowest
7 score
What this shows Dose's Innovation Score is 30.6/100 (top 65% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Dose Health Llc is a focused PatentsView assignee: 5 CPC subclasses with 70% of grants classified under A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2018. By volume, Dose sits between Dongguan Empress Technology Co., Ltd. and Druggability Technologies IP Holdco Limited.
Dose Health Llc shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Dongguan Empress Technology Co., Ltd.
10 patents
Dongguan KangRoad Electrical Technology Co., Ltd.
10 patents
Dongnan Elevator Co., Ltd.
10 patents
Dorner Mfg. Corp.
10 patents
Dragontree Beheer B.V.
10 patents
Dri-Eaz Products, Inc.
10 patents
Drivent LLC
10 patents
Druggability Technologies IP Holdco Limited
10 patents
Dose Health LLC
10 patents
What this shows Dose holds 10 patents at rank #26,163, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,163 in granted patent volume.
Other assignees with the most granted patents in Dose's primary technology class.
Dose's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 Top 65% higher than 35% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 10.0% |
| 2019 | 1 | 10.0% |
| 2020 | 1 | 10.0% |
| 2021 | 2 | 20.0% |
| 2022 | 2 | 20.0% |
| 2023 | 1 | 10.0% |
| 2024 | 2 | 20.0% |
Top 5 of 5 technology areas
Overall rank by patents
#26,150
of 50,000 tracked assignees
30.6 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.